Despite Hype, Broadcom Keeps Edging Sideways and Down: This Wall Street Analyst Says It Will Provide 75% Returns Soon

Alex Sirois

Thu, September 17, 2026 at 3:51 PM GMT+3 7 min read

Quick Read

Broadcom (AVGO) trades at $340, a 57% discount to the consensus target, despite posting nine straight EPS beats and guiding Q4 AI revenue up 236% year-on-year.
Rosenblatt raised its AVGO target to $600, implying 77% upside, anchored by an 18x multiple on FY2028 EPS management says will exceed $30.
AVGO is the only AI chip peer where the price target gap has widened as the share price fell, with NVDA up 15% and MRVL up 171% YTD by comparison.
Just released. Our analysts combed the entire stock market and named the ten best stocks to buy right now, and Broadcom didn't make the cut. Enter your email to see the names that beat AVGO. The report is free. Enter your email and see if any of your stocks made the cut.

Broadcom (NASDAQ:AVGO) currently trades at $339.51, well below the average Wall Street 12-month price target of $531.85, a gap that implies roughly 57% upside from here.

24/7 Wall St.

Broadcom is now the second-largest US semiconductor company by market capitalization at roughly $1.62 trillion, sitting behind only NVIDIA. Its role in the AI buildout has shifted from "one of many" to the custom silicon partner of choice for hyperscalers like Google, Meta, OpenAI, and Anthropic. That is why the disconnect between the fundamentals and the share price has drawn analyst attention.

The setup is unusual. Broadcom just posted its ninth consecutive EPS beat and guided Q4 AI semiconductor revenue to $21.7 billion, up 236% year-on-year. And the stock keeps drifting the wrong way.

Why AVGO Keeps Grinding Lower Despite Blowout Numbers

The headline damage is the one-month move, with the stock down 13.49% against a Q4 revenue guide of roughly $34.8 billion, up 93% year-on-year. The pullback accelerated after CNBC reported Anthropic had pushed Broadcom to slow the pace of AI capacity deployment. Broadcom's chief executive publicly said the underlying AI revenue targets have not changed.

Free Report, Just Released

Why Didn't AVGO Make The Top 10 List?

24/7 Wall St has helped investors make money for over two decades, and our top analysts just finished ranking the definitive Top 10 Stocks To Buy Now. Not the ten biggest companies. Not the ten everyone is arguing about. The ten best stocks to buy right now.

And AVGO didn't make the cut!

The report is free, and you can see why we think each stock is a top investment today.

Enter Your Email and See the Ten →

The bigger issue is positioning. AVGO ran to roughly $495 at its Q2 filing before sliding to $371.27 at the Q3 release, and it has given back more ground since. Investors are questioning whether the fiscal 2028 AI outlook of $230 billion reflects secured supply more than secured demand, and whether concentration among a handful of hyperscaler customers is a strength or a single point of failure.

The selloff has been AVGO-specific rather than a group event. The S&P 500 is up 10.59% YTD, while AVGO is down 1.54% YTD and off 5% over the past year, an outlier among big-cap AI names.

Rosenblatt's $600 Call Frames the Bull Case

Rosenblatt Securities analyst Sajal Dogra raised the firm's price target to $600 from $500 with a Buy rating. Against the current $339.51 quote, that works out to roughly 77% upside, well above the 40% threshold that makes this the analytical centerpiece here.

The math behind $600 is straightforward: an 18x P/E applied to a fiscal 2028 non-GAAP EPS estimate. Management said on the last call it is "very much on target to exceed $30 in earnings per share in fiscal 2028". Rosenblatt argues the multiple is defensible because AI revenue is guided to roughly $115 billion in FY2027 and $230 billion in FY2028, and because actual end-market demand outstrips those figures, with real-world revenue bottlenecked by physical data center power, shell readiness, and deployment pace. All of that buildout has to be powered, cooled, and networked by somebody, and we profiled seven of those suppliers in a free report on the non-chip winners of the AI boom.

Socket quality matters just as much. Broadcom is shipping Ironwood TPU v7 in high volume to Google and has begun production shipments of TPU v8i, which CEO Hock Tan said is "comparable if not surpasses the Vera Rubin GPU". Anthropic is on track to become Broadcom's largest XPU customer in fiscal 2027, with OpenAI's Jalapeno accelerator scaling to a planned 1.3-gigawatt deployment the same year. Rosenblatt concedes Broadcom's incremental TPU market share may taper from roughly 80% to 85% today toward 60% to 65% by FY2027, but higher dollar content per socket should offset the unit dilution.

The Street is aligned on direction. Of 49 covering analysts, 8 have it Strong Buy, 37 Buy, 4 Hold, and zero Sells. Fiscal 2027 EPS estimates have been revised up 6 times in the past 30 days against 1 downward revision.

How the AI Chip Peer Group Stacks Up

Broadcom fell alone while the group held up.

NVIDIA (NASDAQ:NVDA) trades at $213.90 against a $328.66 average target, roughly 54% implied upside. It is up 14.96% YTD, with 57 of 60 covering analysts at Buy or Strong Buy, and Data Center revenue up 117% year-on-year last quarter.

Advanced Micro Devices (NASDAQ:AMD) sits at $512.50 with a $616.51 target, only about 20% upside. AMD is up 139.31% YTD after Data Center revenue grew 107% year-on-year. Posture is mostly Buy with 11 Holds mixed in. The Street has largely caught up here.

Marvell Technology (NASDAQ:MRVL) trades at $229.71 against a $289.04 target, roughly 26% upside. Its custom silicon story has re-rated the shares 170.7% YTD, leaving less room to run despite a supportive analyst posture.

The largest analyst-implied upside in the group sits with AVGO, and it is not close. Broadcom is the only name here where the target has widened against a falling share price. Targets are one data point among many, but the direction is telling.

Numbers Behind the Dislocation

Broadcom trades at $339.51 with a 12-month consensus target of $531.85 across 49 analysts, implying roughly 57% upside. Shares are down 6.83% over the past week and 13.49% over the past month. Year-to-date, AVGO is off 1.54% while the S&P 500 is up 10.59%, a roughly 12-point gap against the benchmark.

Analyst ratings breakdown:

Strong Buy: 8
Buy: 37
Hold: 4
Sell: 0
Strong Sell: 0

Forward valuation is where the tension lives. On fiscal 2027 consensus EPS of $19.3839 across 47 analysts, AVGO trades at roughly 18x forward earnings, essentially in line with the multiple Rosenblatt applied to its 2028 estimate. The trailing P/E of 43 looks steep, while the forward multiple looks reasonable.

Bull and Bear Cases for AVGO From Here

The bull case works if fiscal 2028 AI semiconductor revenue lands anywhere near the $230 billion Hock Tan is guiding to, and if Anthropic, OpenAI, and Google keep validating custom silicon at the current pace. In that world, the Rosenblatt $600 target is not aggressive, and today's $339.51 quote is a gift. Analyst targets are not guarantees, but the path back involves execution on already-secured supply.

The bear case builds if the Anthropic pace-slowing story is a leading indicator rather than a one-off, or if the residual value exposure sitting inside Broadcom's XPU financing platform with Apollo and Blackstone quietly grows. Customer concentration cuts both ways: three or four hyperscalers changing their capex cadence would reprice this stock overnight.

The setup skews bullish. Too many blowout data points, too much analyst conviction, and too clean a fiscal 2028 EPS bridge to ignore just because the recent price action has been ugly.

Got $1,000? Before You Buy AVGO, Read This

If you have cash sitting in your account right now, give this two minutes. After more than two decades of helping investors beat the market, our top analysts at 24/7 Wall St. put together a definitive report on the Top 10 Stocks To Buy Today. And AVGO wasn't one of them.

They combed the entire market. It's not 10 ideas, not 10 stocks everyone is talking about, it's what their research points to as the 10 best stocks to buy right now, and it's free. Read more here and see which stocks made the list -->>

Contact editorial@247wallst.com for any questions or corrections.